These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29916447)

  • 21. Heterogeneity of humoral immune response to Leishmania tropica in an experimental model.
    Rostamian M; Akya A; Niknam HM
    Parasitol Res; 2019 Apr; 118(4):1231-1237. PubMed ID: 30778754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
    Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
    J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
    Aguiar MG; Silva DL; Nunan FA; Nunan EA; Fernandes AP; Ferreira LA
    J Antimicrob Chemother; 2009 Dec; 64(6):1234-40. PubMed ID: 19825819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB/c mice.
    Elikaee S; Mohebali M; Rezaei S; Eslami H; Khamesipour A; Keshavarz H; Eshraghian MR
    Vaccine; 2019 May; 37(24):3221-3228. PubMed ID: 31047672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated intravenous injection of adipose tissue derived mesenchymal stem cells enhances Th1 immune responses in Leishmania major-infected BALB/c mice.
    Zanganeh E; Soudi S; Zavaran Hosseini A; Khosrojerdi A
    Immunol Lett; 2019 Dec; 216():97-105. PubMed ID: 31622634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic effects of mesenchymal stem cells on cutaneous leishmaniasis lesions caused by Leishmania major.
    Navard SH; Rezvan H; Haddad MHF; Ali SA; Nourian A; Eslaminejad MB; Behmanesh MA
    J Glob Antimicrob Resist; 2020 Dec; 23():243-250. PubMed ID: 32977079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of cryotherapy plus topical Juniperus excelsa M. Bieb cream versus cryotherapy plus placebo in the treatment of Old World cutaneous leishmaniasis: A triple-blind randomized controlled clinical trial.
    Parvizi MM; Handjani F; Moein M; Hatam G; Nimrouzi M; Hassanzadeh J; Hamidizadeh N; Khorrami HR; Zarshenas MM
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005957. PubMed ID: 28981503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous leishmaniasis in northwestern Saudi Arabia: identification of sand fly fauna and parasites.
    Haouas N; Amer O; Alshammri FF; Al-Shammari S; Remadi L; Ashankyty I
    Parasit Vectors; 2017 Nov; 10(1):544. PubMed ID: 29096693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection and chronology of parasitic kinetoplast DNA presence in hair of experimental Leishmania major infected BALB/c mice by Real Time PCR.
    Iniesta V; Belinchón-Lorenzo S; Soto M; Fernández-Cotrina J; Muñoz-Madrid R; Monroy I; Baz V; Gómez-Luque A; Parejo JC; Alonso C; Nieto LC
    Acta Trop; 2013 Dec; 128(3):468-72. PubMed ID: 23916508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leishmanicidal potentials of
    Sharifi F; Sharififar F; Pournamdari M; Ansari M; Tavakoli Oliaee R; Bamorovat M; Khosravi A; Keyhani AR; Salarkia E; Mortazaeizdeh A; Dabiri S; Khamesipour A; Sharifi I
    J Med Microbiol; 2021 Jun; 70(6):. PubMed ID: 34115583
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of In Vivo Imaging System Technology in Leishmania major BALB/c Mouse Ear Infection Studies.
    Cawlfield A; Vesely B; Ngundam F; Butler K; Nugent D; Rowland T; Caridha D
    J Med Entomol; 2018 Feb; 55(2):429-435. PubMed ID: 29253231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Leishmania major parasite with peptides derived from a combinatorial phage display library.
    Rhaiem RB; Houimel M
    Acta Trop; 2016 Jul; 159():11-9. PubMed ID: 26995695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice.
    Salari S; Sharifi I; Keyhani AR; Ghasemi Nejad Almani P
    Parasit Vectors; 2020 Aug; 13(1):415. PubMed ID: 32787908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient knockdown of
    Tohidi F; Babaei Z; Kazemi B; Bandehpour M; Sharifi I; Rabiei MR; Dezaki ES
    J Vector Borne Dis; 2019; 56(2):98-104. PubMed ID: 31397384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunodetection and molecular determination of visceral and cutaneous Leishmania infection using patients' urine.
    Mirzaei A; Ahmadipour F; Cannet A; Marty P; Delaunay P; Perrin P; Dorkeld F; Sereno D; Akhoundi M
    Infect Genet Evol; 2018 Sep; 63():257-268. PubMed ID: 29847780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis.
    Khadem F; Jia P; Mou Z; Feiz Barazandeh A; Liu D; Keynan Y; Uzonna JE
    J Antimicrob Chemother; 2017 Feb; 72(2):467-477. PubMed ID: 27999013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.
    Monge-Maillo B; López-Vélez R
    Drugs; 2013 Nov; 73(17):1889-920. PubMed ID: 24170665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice.
    Kalat SA; Khamesipour A; Bavarsad N; Fallah M; Khashayarmanesh Z; Feizi E; Neghabi K; Abbasi A; Jaafari MR
    Exp Parasitol; 2014 Aug; 143():5-10. PubMed ID: 24780938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice.
    Moosavian SA; Fallah M; Jaafari MR
    Exp Parasitol; 2019 May; 200():30-35. PubMed ID: 30898544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leishmania sp. isolated from human cases of cutaneous leishmaniasis in Brazil characterized as Leishmania major-like.
    Silva Sde O; Wu AA; Evans DA; Vieira LQ; Melo MN
    Acta Trop; 2009 Dec; 112(3):239-48. PubMed ID: 19660430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.